About Boston Genetics
Boston Genetics is a company based in Cambridge (United States) founded in 2019 was acquired by Genomenon in June 2023. Boston Genetics operates in a competitive market with competitors including Blue Rock Therapeutics, CellCarta, Ascend, Impel Pharmaceuticals and Shanghai Cell Therapy Group, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Boston Genetics
Detailed funding history for Boston Genetics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Boston Genetics
Boston Genetics has secured backing from 1 investor. Prominent investors backing the company include Genomenon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-based bioinformatics tools and genomic variants meta-database are developed.
|
Locked | Locked | Locked |
Investor details for Boston Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boston Genetics
Investment portfolio details for Boston Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Boston Genetics
Detailed financials for Boston Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Boston Genetics Comparisons
Peer comparison for Boston Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Boston Genetics
Boston Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, CellCarta, Ascend, Impel Pharmaceuticals and Shanghai Cell Therapy Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| Locked | Locked | Locked |
Histopathology and genomics services are offered by the CRO.
|
|
| Locked | Locked | Locked |
Online insurance payments and premium financing are enabled for businesses.
|
|
| Locked | Locked | Locked |
Transformative therapies are developed and commercialized through specialized services.
|
|
| Locked | Locked | Locked |
Research and development services for cell therapy are provided.
|
|
| Locked | Locked | Locked |
Online supplier and developer of RNA based products
|
Detailed competitors of Boston Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Boston Genetics
Complete news archive for Boston Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boston Genetics
Boston Genetics was founded in 2019.
Boston Genetics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Boston Genetics was established in 2019 in Cambridge, United States, within the biotechnology sector. Focus is placed on gene therapy-based drug development services, where preclinical and clinical support are offered to clients. Operations center on advancing therapeutic innovations through genetic approaches. Expertise is applied in areas such as vector design and regulatory compliance, serving pharmaceutical partners across the region. The companys domain, bostongen.com, facilitates client interactions and resource access.
Boston Genetics's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
Boston Genetics has 1 investor. Key investors include Genomenon.